Literature DB >> 5101320

Intramuscular lidocaine in the therapy of ventricular arrhythmias.

S Bellet, L Roman, J B Kostis, D Fleischmann.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5101320     DOI： 10.1016/0002-9149(71)90305-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.

Authors:  D P Vaughan; G T Tucker
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

3.  Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.

Authors:  L Rydén; A Waldenström; L Ehn; S Holmberg; M Husaini
Journal:  Br Heart J       Date:  1973-11

4.  Common errors in the treatment of cardiac patients.

Authors:  T Banks; N Ali; D Lee
Journal:  J Natl Med Assoc       Date:  1973-07       Impact factor: 1.798

5.  Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction.

Authors:  L Rydén; H Wasir; T B Conradsson; B Olsson
Journal:  Br Heart J       Date:  1972-10

Review 6.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

Review 8.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

Review 9.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

Review 10.  Reliability of antiarrhythmic drug plasma concentration monitoring.

Authors:  F Follath; U Ganzinger; E Schuetz
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.